Related coverage linked through entity extraction aliases.
May 24, 2026
Axol Bioscience has acquired the ophthalmology business of Newcells Biotech, adding advanced retinal organoid and 2D RPE models to its iPSC portfolio. The deal follows Axol's acquisition of Phenocell and a $2.8 million financing led by BroadOak Capital Partners. Financial terms were not disclosed.
Aug 08, 2026
Recent studies on metformin and age-related macular degeneration report conflicting findings: a JAMA Ophthalmology cohort found no association, while studies in Ophthalmology Retina and BMJ Open Ophthalmology found reduced odds of neovascular and intermediate AMD, respectively. All were observational.
Jun 18, 2026
Immune checkpoint inhibitors are associated with a significantly lower risk of non-neovascular age-related macular degeneration, while sociodemographic disparities strongly influence diabetic retinopathy screening adherence, according to two separate ophthalmology studies.
Mar 13, 2026
Zydus Lifesciences launched ANYRA, India's first indigenously developed aflibercept biosimilar, on February 19, 2026, following an agreement with Regeneron Pharmaceuticals and Bayer for multiple ophthalmic indications.
